JW (Cayman) Therapeutics Issues Share Options, RSUs to Two Employees

MT Newswires Live

2025/01/07

JW (Cayman) Therapeutics (HKG:2126) granted a total of 387,740 share options and 77,548 restricted share units (RSU) to two grantees on Monday, a same-day bourse filing said.

The options and RSUs were granted under the drugmaker's post-IPO incentivization and restricted share unit schemes.

Each option entitles the grantees, which are employees of the firm, to subscribe for one share at HK$1.36 apiece starting Jan. 6, 2025, and ending Jan. 5, 2035.

Each RSU, which is valid between Jan. 6, 2025, and Jan. 5, 2035, also allows the grantees to receive one share subject to vesting.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2501275182"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2501275182\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2501275182?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-07 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501275182","market":"hk","top_or_hot":-1,"title":"JW (Cayman) Therapeutics Issues Share Options, RSUs to Two Employees","media":"MT Newswires Live","content":"<html><body><p> JW (Cayman) <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HKG:2126) granted a total of 387,740 share options and 77,548 restricted share units (RSU) to two grantees on Monday, a same-day bourse filing said.</p><p>The options and RSUs were granted under the drugmaker's post-IPO incentivization and restricted share unit schemes.</p><p>Each option entitles the grantees, which are employees of the firm, to subscribe for one share at HK$1.36 apiece starting Jan. 6, 2025, and ending Jan. 5, 2035.</p><p>Each RSU, which is valid between Jan. 6, 2025, and Jan. 5, 2035, also allows the grantees to receive one share subject to vesting.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JW (Cayman) Therapeutics Issues Share Options, RSUs to Two Employees</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJW (Cayman) Therapeutics Issues Share Options, RSUs to Two Employees\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-07 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> JW (Cayman) <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HKG:2126) granted a total of 387,740 share options and 77,548 restricted share units (RSU) to two grantees on Monday, a same-day bourse filing said.</p><p>The options and RSUs were granted under the drugmaker's post-IPO incentivization and restricted share unit schemes.</p><p>Each option entitles the grantees, which are employees of the firm, to subscribe for one share at HK$1.36 apiece starting Jan. 6, 2025, and ending Jan. 5, 2035.</p><p>Each RSU, which is valid between Jan. 6, 2025, and Jan. 5, 2035, also allows the grantees to receive one share subject to vesting.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2501275182","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501275182","pubTimestamp":1736240731,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"JW  Therapeutics  granted a total of 387,740 share options and 77,548 restricted share units  to two grantees on Monday, a same-day bourse filing said.The options and RSUs were granted under the drugmaker's post-IPO incentivization and restricted share unit schemes.Each option entitles the grantees, which are employees of the firm, to subscribe for one share at HK$1.36 apiece starting Jan. 6, 2025, and ending Jan. 5, 2035.Each RSU, which is valid between Jan. 6, 2025, and Jan. 5, 2035, also allows the grantees to receive one share subject to vesting.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","BK1574":"生物医药B类股","BK4139":"生物科技","BK1583":"高瓴概念","02126":"药明巨诺-B","LENZ":"Therapeutics"},"translate_title":"JW(Cayman)Therapeutics向两名僱员发行购股权、受限制股份单位","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02126":0.9,"LENZ":1},"content_text":"JW (Cayman) Therapeutics (HKG:2126) granted a total of 387,740 share options and 77,548 restricted share units (RSU) to two grantees on Monday, a same-day bourse filing said.The options and RSUs were granted under the drugmaker's post-IPO incentivization and restricted share unit schemes.Each option entitles the grantees, which are employees of the firm, to subscribe for one share at HK$1.36 apiece starting Jan. 6, 2025, and ending Jan. 5, 2035.Each RSU, which is valid between Jan. 6, 2025, and Jan. 5, 2035, also allows the grantees to receive one share subject to vesting.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}